Neuroinflammation in Disease
Risk Factors, Management & Outcomes
Seiten
2015
Nova Science Publishers Inc (Verlag)
978-1-63483-389-9 (ISBN)
Nova Science Publishers Inc (Verlag)
978-1-63483-389-9 (ISBN)
In this book, the link between the modifiable risk factors of neurodegenerative diseases and chronic neuroinflammation are examined, thus highlighting that controlling risk factors is a valid approach for managing neurodegnerative diseases in which neuroinflammation contributes to the disease progression. The mechanisms of inhibition of neuroinflammation by EST and ERAs are discussed, as well as the neuroprotective roles of EST and ERAs in multiple sclerosis, Alzheimer's disease, Parkinson's disease and epilepsy. The final chapter focuses on the dynamics of progression in MS patients, and the disease process within contexts of proinflammatory reactivity and interactivity.
Preface; An Interplay between Neuroinflammation and Modifiable Risk Factors of Alzheimers Disease, Parkinsons Disease and Amyotrophic Lateral Sclerosis; Therapeutic Effects of Estrogen Receptor Agonists in Inhibition of Neuroinflammation in Different Neurological Disorders; Dynamics of Establishment of Proinflammation as Signature Perivascular Injury in Multiple Sclerosis Neuroparenchyma; Index.
Verlagsort | New York |
---|---|
Sprache | englisch |
Maße | 155 x 230 mm |
Gewicht | 174 g |
Themenwelt | Medizin / Pharmazie ► Medizinische Fachgebiete ► Neurologie |
Studium ► 2. Studienabschnitt (Klinik) ► Pathologie | |
Naturwissenschaften ► Biologie ► Humanbiologie | |
Naturwissenschaften ► Biologie ► Zoologie | |
ISBN-10 | 1-63483-389-9 / 1634833899 |
ISBN-13 | 978-1-63483-389-9 / 9781634833899 |
Zustand | Neuware |
Haben Sie eine Frage zum Produkt? |
Mehr entdecken
aus dem Bereich
aus dem Bereich
Klinisch-pathologische Übersichtskarten
Buch | Hardcover (2023)
Springer (Verlag)
CHF 48,95